World's best-performing IPO in 2021 is a Korean bioscience firm
newsdepo.com
South Korean biopharmaceutical firm SK Bioscience's IPO raised $1.3 billion for the firm, which is a local Covid-19 vaccine-production partner with AstraZeneca Plc.World's best-performing IPO in 2021 is a Korean bioscience firm
South Korean biopharmaceutical firm SK Bioscience's IPO raised $1.3 billion for the firm, which is a local Covid-19 vaccine-production partner with AstraZeneca Plc. Read more